News + Filings Transactions Holdings
|
|
Ikarian Capital, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
Sarepta Therapeutics, Inc.
| SRPT | CALL | 22,100 | -183,300 | 2,530,892,000 | -25,779,390,000 | 0.40 | |
Hist
| 06/30/2023 |
|
Sarepta Therapeutics, Inc.
| SRPT | PUT | 122,100 | -149,200 | 13,982,892,000 | -23,410,387,000 | 2.23 | |
Hist
| 06/30/2023 |
|
REATA PHARMACEUTICALS INC
| RETA | Common | 5,472 | -75,092 | 557,925,000 | -6,766,954,000 | 0.09 | |
Hist
| 06/30/2023 |
|
Astria Therapeutics, Inc.
| ATXS | Common | 579,390 | -290,000 | 4,826,318,000 | -6,736,569,000 | 0.77 | 2.07 |
Hist
| 06/30/2023 |
|
Terns Pharmaceuticals, Inc.
| TERN | Common | 315,480 | -405,861 | 2,760,451,000 | -5,780,226,000 | 0.44 | 0.56 |
Hist
| 06/30/2023 |
|
BridgeBio Pharma, Inc.
| BBIO | Common | 429,686 | -165,000 | 7,390,599,000 | -2,469,295,000 | 1.18 | 0.27 |
Hist
| 06/30/2023 |
|
Merus N.V.
| MRUS | COM | 63,125 | -145,525 | 1,662,081,000 | -2,177,080,000 | 0.26 | |
Hist
| 06/30/2023 |
|
Roivant Sciences Ltd.
| ROIV | COM | 225,000 | -350,000 | 2,267,999,000 | -1,975,501,000 | 0.36 | |
Hist
| 06/30/2023 |
|
ARDELYX, INC.
| ARDX | COM | 278,825 | -300,000 | 945,216,000 | -1,827,356,000 | 0.15 | 0.14 |
Hist
| 06/30/2023 |
|
Vaxcyte, Inc.
| PCVX | Common | 140,000 | -85,000 | 6,991,600,000 | -1,441,400,000 | 1.11 | 0.15 |
Hist
| 06/30/2023 |
|
POINT Biopharma Global Inc.
| PNT | Common | 28,784 | -110,781 | 260,783,000 | -753,856,000 | 0.04 | 0.03 |
Hist
| 06/30/2023 |
|
Kodiak Sciences Inc.
| KOD | Common | 62,527 | -100,000 | 431,436,000 | -576,232,000 | 0.07 | |
Hist
| 06/30/2023 |
|
OCULAR THERAPEUTIX, INC
| OCUL | COM | 100,000 | -100,000 | 516,000,000 | -538,000,000 | 0.08 | 0.13 |
Hist
| 06/30/2023 |
|
Xenon Pharmaceuticals Inc.
| XENE | COM | 135,486 | -25,000 | 5,216,212,000 | -527,581,000 | 0.83 | 0.21 |
Hist
| 06/30/2023 |
|
Jasper Therapeutics, Inc.
| JSPR | Common | 1,125,087 | -1,200 | 1,541,370,000 | -497,209,000 | 0.25 | 1.03 |
Hist
| 06/30/2023 |
|
Aclaris Therapeutics, Inc.
| ACRS | COM | 200,163 | -100,000 | 2,075,690,000 | -352,629,000 | 0.33 | 0.28 |
Hist
| 06/30/2023 |
|
Erytech Pharma S.A.
| ERYP | Common | 3,019 | -245,407 | 2,257,000 | -249,854,000 | 0.00 | |
Hist
| 06/30/2023 |
|
Chemomab Therapeutics Ltd.
| CMMB | SPONSORED ADS | 213,392 | -23,317 | 279,543,000 | -62,548,000 | 0.04 | |
Hist
| 06/30/2023 |
|
Immatics N.V.
| IMTX | Common | 49,031 | -130,521 | 565,817,000 | 39,551,000 | 0.09 | 0.06 |
Hist
| 06/30/2023 |
|
Protagonist Therapeutics, Inc
| PTGX | CALL | 200,000 | -11,400 | 5,524,000,000 | 661,800,000 | 0.88 | |
Hist
| 06/30/2023 |
|
BICYCLE THERAPEUTICS plc
| BCYC | SPONSORED ADS | 203,037 | -4,075 | 5,181,504,000 | 776,231,000 | 0.83 | |
Hist
| 06/30/2023 |
|
|
|
|